Levels of CEACAM6 in Peripheral Blood Are Elevated in Patients with Plasma Cell Disorders: A Potential New Diagnostic Marker and a New Therapeutic Target?

Normann SteinerR HajekD NachbaurB BorjanS SevcikovaG GöbelE Gunsilius

Published in: Disease markers (2019)

CEACAM6 plasma levels can noninvasively identify pts. with a plasma cell disorder and should be evaluated prospectively as a potential diagnostic marker. Moreover, due to high CEACAM6 levels in the bone marrow in RRMM pts., this adhesion molecule might be a therapeutic target in multiple myeloma pts.

Keyphrases

bone marrow
peripheral blood
single cell
multiple myeloma
cell therapy
mesenchymal stem cells
stem cells
human health
risk assessment
biofilm formation
cystic fibrosis